Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by ...
Americans Skip Overseas Travel as Stem Cell and Exosome Therapy Arrives at 5 US Locations New York, United States - May ...
A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), Volume 16, Issue 17 on September 9, 2024, entitled, "The ...
HexemBio emerges with a breakthrough blood stem cell rejuvenation technology led by Draper Associates and an advisory board that includes Co-Founder of Moderna SAN ...
How Micro FUE Hair Transplants Combined With Stem Cell Exosome Therapy May Support Better Results New York, United ...
Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, today announced the publication of new research ...
Extending human health span by several years is the vision of clock.bio, a biotech startup that is investigating the biology of cellular rejuvenation. The company recently raised $5.3 million in seed ...
There is a saying, "muscle over pension." It means muscle matters more than money for a happy old age. When aging accelerates abnormally and frailty sets in, muscle drops sharply, making one prone to ...
Investment led by BGF, with support from existing investors F-Prime Capital, Kindred Capital, and Jonathan Milner Seed funding will accelerate development of Shift Bioscience’s platform for ...
The Berkeley biotech is backing a Nature-published approach that recreates the embryonic environment where blood stem cells first form, rather than reprogramming aged cells chemically or genetically.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results